Literature DB >> 21791653

The impact of fasting on the interpretation of triglyceride levels for predicting myocardial infarction risk in HIV-positive individuals: the D:A:D study.

.   

Abstract

We assessed whether fasting modifies the prognostic value of these measurements for the risk of myocardial infarction (MI). Analyses used mixed effect models and Poisson regression. After confounders were controlled for, fasting triglyceride levels were, on average, 0.122 mmol/L lower than nonfasting levels. Each 2-fold increase in the latest triglyceride level was associated with a 38% increase in MI risk (relative rate, 1.38; 95% confidence interval, 1.26-1.51); fasting status did not modify this association. Our results suggest that it may not be necessary to restrict analyses to fasting measurements when considering MI risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791653      PMCID: PMC3203386          DOI: 10.1093/infdis/jir329

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism.

Authors:  Henry N Ginsberg
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

2.  Metabolic and skeletal complications of HIV infection: the price of success.

Authors:  Caryn G Morse; Joseph A Kovacs
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

3.  Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?

Authors:  Paul M Ridker
Journal:  Clin Chem       Date:  2007-11-12       Impact factor: 8.327

4.  Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infection.

Authors:  James H Stein; Michelle A Merwood; Jennifer B Bellehumeur; Patrick E McBride; Donald A Wiebe; James M Sosman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-02       Impact factor: 8.311

5.  Major lipids, apolipoproteins, and risk of vascular disease.

Authors:  Emanuele Di Angelantonio; Nadeem Sarwar; Philip Perry; Stephen Kaptoge; Kausik K Ray; Alexander Thompson; Angela M Wood; Sarah Lewington; Naveed Sattar; Chris J Packard; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-11-11       Impact factor: 56.272

Review 6.  Induction of atherosclerosis by human chylomicron remnants: a hypothesis.

Authors:  Monica G Wilhelm; Allen D Cooper
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

7.  Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.

Authors:  Lynn E Eberly; Jeremiah Stamler; James D Neaton
Journal:  Arch Intern Med       Date:  2003-05-12

8.  Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.

Authors:  Sandeep Bansal; Julie E Buring; Nader Rifai; Samia Mora; Frank M Sacks; Paul M Ridker
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

9.  Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Authors:  Børge G Nordestgaard; Marianne Benn; Peter Schnohr; Anne Tybjaerg-Hansen
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

10.  Combination antiretroviral therapy and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa M El-Sadr; Peter Reiss; Rodolphe Thiébaut; Linda Morfeldt; Stephane De Wit; Christian Pradier; Gonzalo Calvo; Matthew G Law; Ole Kirk; Andrew N Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.